This is in line with the current immunologic paradigm that impaired DNA repair (high PARP1 expression as its potential histopathologic surrogate) increases neoantigen load and tumoral immunogenicity (enhanced PD-L1 expression on tumor cells as an immunohistochemical equivalent of adoptive immune response). Here, PARP1 is linked to neoplasm.